Increasing evidence suggests that CD44 is extensively overexpressed in other cancer types including gallbladder, prostate, ovarian, oral squamous cell carcinoma, and gastric cancer, correlating with aggressive biological behavior and a poor prognosis39. This evidence concerns the gene CD44 and cancer.